Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations
Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Department of Dermatology, Venereology and Allergology, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
St John's Institute of Dermatology, London, United Kingdom.
Academic Medical Centre Amsterdam, Amsterdam, Netherlands.
Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Department of Dermatology, Venereology and Allergology, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Show others and affiliations
2021 (English)In: Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, E-ISSN 1468-3083, Vol. 35, no 2, p. 281-317Article in journal (Refereed) Published
Abstract [en]

This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clinical and comorbid situations such as treating psoriasis vulgaris patient with concomitant psoriatic arthritis, concomitant inflammatory bowel disease, a history of malignancies or a history of depression or suicidal ideation. It further holds recommendations for concomitant diabetes, viral hepatitis, disease affecting the heart or the kidneys as well as concomitant neurological disease. Advice on how to screen for tuberculosis and recommendations on how to manage patients with a positive tuberculosis test result are given. It further covers treatment for pregnant women or patients with a wish for a child in the near future. Information on vaccination, immunogenicity and systemic treatment during the COVID-19 pandemic is also provided.

Place, publisher, year, edition, pages
John Wiley & Sons, 2021. Vol. 35, no 2, p. 281-317
National Category
Dermatology and Venereal Diseases
Identifiers
URN: urn:nbn:se:umu:diva-180794DOI: 10.1111/jdv.16926ISI: 000615217300035Scopus ID: 2-s2.0-85100540361OAI: oai:DiVA.org:umu-180794DiVA, id: diva2:1531159
Available from: 2021-02-25 Created: 2021-02-25 Last updated: 2023-09-05Bibliographically approved

Open Access in DiVA

fulltext(1340 kB)1283 downloads
File information
File name FULLTEXT01.pdfFile size 1340 kBChecksum SHA-512
2205151ff0d2399204029dfd27fb09954e48f8377c0ae9de1107f43dae01506d362f88928eb1fd46d68ef23714f5c96ffb1f5a1e83209ba285d56f1077feec5e
Type fulltextMimetype application/pdf

Other links

Publisher's full textScopus

Authority records

Schmitt-Egenolf, Marcus

Search in DiVA

By author/editor
Schmitt-Egenolf, Marcus
By organisation
Dermatology and Venerology
In the same journal
Journal of the European Academy of Dermatology and Venereology
Dermatology and Venereal Diseases

Search outside of DiVA

GoogleGoogle Scholar
Total: 1286 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 267 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf